| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institut National de la Santé et de la Recherche Médicale and Université Pierre et Marie Curie, Hopital Saint-Antoine, Paris, France
The absence of a detectable immune response during transmissible spongiform encephalopathies is likely due to the fact that the essential component of infectious agents, the prion protein (PrP), is a self Ag expressed on the surface of many cells of the host. To overcome self-tolerance to PrP, we used 30-mer PrP peptides previously shown to be immunogenic in Prnp–/– mice, together with CFA or CpG-oligodeoxynucleotides (CpG) in IFA. Generation of anti-PrP T and B cell responses was analyzed in the spleen, lymph nodes, and serum of immunized C57BL/6 wild-type mice. Immunization with PrP peptides emulsified in CFA did not trigger an immune response to PrP. When CpG were used, vaccination with peptides P143–172 and P158–187 generated IFN-
-secreting splenic T cells, and only P158–187 significantly stimulated IL-4-secreting T cells. Both peptides induced few Ab-producing B cells, and low and variable serum Ab titers. In contrast, immunization with peptide P98–127 did not induce significant levels of T cell responses but elicited specific peptide Abs. T cell epitope mapping, performed using 15-mer peptides covering PrP segment 142–182, revealed that an immunogenic motif lies between positions 156 and 172. These results demonstrate that T and B cell repertoires against PrP can be stimulated in C57BL/6 when adjuvant of the innate immunity such as CpG, but not CFA, is added to PrP peptides, and that the pattern of immune responses varies according to the epitope.
This article has been cited by other articles:
|
|
 |
|
  A. Sacquin, A. S. Bergot, P. Aucouturier, and M. Bruley-Rosset Contribution of Antibody and T Cell-Specific Responses to the Progression of 139A-Scrapie in C57BL/6 Mice Immunized with Prion Protein Peptides J. Immunol., July 1, 2008; 181(1): 768 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. van Ginkel, T. Iwamoto, B. D. Schultz, and J. M. Tomich Immunity to a Self-Derived, Channel-Forming Peptide in the Respiratory Tract Clin. Vaccine Immunol., February 1, 2008; 15(2): 260 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kaiser-Schulz, A. Heit, L. Quintanilla-Martinez, F. Hammerschmidt, S. Hess, L. Jennen, H. Rezaei, H. Wagner, and H. M. Schatzl Polylactide-Coglycolide Microspheres CoEncapsulating Recombinant Tandem Prion Protein with CpG-Oligonucleotide Break Self-Tolerance to Prion Protein in Wild-Type Mice and Induce CD4 and CD8 T Cell Responses J. Immunol., September 1, 2007; 179(5): 2797 - 2807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Spinner, R. B. Kascsak, G. LaFauci, H. C. Meeker, X. Ye, M. J. Flory, J. I. Kim, G. B. Schuller-Levis, W. R. Levis, T. Wisniewski, et al. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils J. Leukoc. Biol., June 1, 2007; 81(6): 1374 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fernandez-Borges, A. Brun, J. L. Whitton, B. Parra, F. Diaz-San Segundo, F. J. Salguero, J. M. Torres, and F. Rodriguez DNA Vaccination Can Break Immunological Tolerance to PrP in Wild-Type Mice and Attenuates Prion Disease after Intracerebral Challenge. J. Virol., October 1, 2006; 80(20): 9970 - 9976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Andrievskaia, H. McRae, C. Elmgren, H. Huang, A. Balachandran, and K. Nielsen Generation of Antibodies against Bovine Recombinant Prion Protein in Various Strains of Mice Clin. Vaccine Immunol., January 1, 2006; 13(1): 98 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gregoire, A. S. Bergot, C. Feraudet, C. Carnaud, P. Aucouturier, and M. B. Rosset The Murine B Cell Repertoire Is Severely Selected against Endogenous Cellular Prion Protein J. Immunol., November 15, 2005; 175(10): 6443 - 6449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nikles, P. Bach, K. Boller, C. A. Merten, F. Montrasio, F. L. Heppner, A. Aguzzi, K. Cichutek, U. Kalinke, and C. J. Buchholz Circumventing Tolerance to the Prion Protein (PrP): Vaccination with PrP-Displaying Retrovirus Particles Induces Humoral Immune Responses against the Native Form of Cellular PrP J. Virol., April 1, 2005; 79(7): 4033 - 4042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Polymenidou, F. L. Heppner, E. C. Pellicioli, E. Urich, G. Miele, N. Braun, F. Wopfner, H. M. Schatzl, B. Becher, and A. Aguzzi Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection PNAS, October 5, 2004; 101(suppl_2): 14670 - 14676. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
